TABLE 1.
Strains used in this study
| Strain | Parental strain | Genotype | Reference |
|---|---|---|---|
| CAF2-1 | SC5314 | ura3Δ∷imm434/URA3 | Fonzi and Irwin (1993) |
| CAF4-2 | CAF2-1 | ura3Δ∷imm434/ura3Δ∷imm434 | Fonzi and Irwin (1993) |
| DSY2875 | CAF4-2 | tac1-1Δ∷hisG/TAC1-2 | Coste et al. (2004) |
| DSY2903 | DSY2875 | tac1-1Δ∷hisG/tac1-2Δ∷hisG-URA-hisG | Coste et al. (2004) |
| DSY2906 | DSY2903 | tac1-1Δ∷hisG/tac1-2Δ∷hisG | Coste et al. (2004) |
| DSY2937-35 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG, LEU2∷TAC1 | Coste et al. (2004) |
| DSY2925-47 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG, LEU2∷TAC1-3 | Coste et al. (2004) |
| DSY2925-18 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG, LEU2∷TAC1-4 | Coste et al. (2004) |
| DSY2984 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG, LEU2∷TAC1-5 | This study |
| VTY9 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG, LEU2∷TAC1-5D977N | This study |
| VTY21 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG, LEU2∷TAC1-1N977D | This study |
| VTY28 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG, LEU2∷TAC1-4N977D | This study |
| DSY3010-80 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG,LEU2∷TAC1-6 | This study |
| DSY3010-113 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG,LEU2∷TAC1-7-FH1 | This study |
| DSY3013 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG,LEU2∷TAC1-7-FH3 | This study |
| ACY11 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG,LEU2∷TAC1-6N977D | This study |
| ACY12 | DSY2906 | tac1-1Δ∷hisG/tac1-2Δ∷hisG,LEU2∷TAC1-7D977N | This study |
| DSY294 | Azole-susceptible clinical strain (MTLa/MTLα) | Coste et al. (2004) | |
| DSY3040 | DSY294 | ura3Δ∷FRT/ura3Δ∷FRT | This study |
| DSY3058 | DSY3040 | TAC1-4/tac1-3Δ∷hisG-URA3-hisG | This study |
| DSY3075 | DSY3058 | TAC1-4/tac1-3Δ∷hisG | This study |
| DSY3082 | DSY3075 | tac1-3Δ∷hisG/tac1-4Δ∷hisG-URA3-hisG | This study |
| DSY3089 | DSY3082 | tac1-3Δ∷hisG/tac1-4Δ∷hisG | This study |
| DSY3102-2 | DSY3089 | tac1-3Δ∷hisG/tac1-4Δ∷hisG, LEU2∷TAC1-5 | This study |
| DSY3287-1 | DSY3089 | tac1-3Δ∷hisG/tac1-4Δ∷hisG, LEU2∷TAC1-3 | This study |
| DSY 3288-3 | DSY3089 | tac1-3Δ∷hisG/tac1-4Δ∷hisG, LEU2∷TAC1-4 | This study |
| DSY3053-1 | DSY3040 | TAC1-4/tac1-3Δ∷hisG-URA3-hisG | This study |
| DSY3168-1 | DSY3053-1 | TAC1-4/tac1-3Δ∷hisG | This study |
| DSY3219-2 | DSY3168 | TAC1-4/tac1-3Δ∷hisG, tac1∷TAC1-5 | This study |
| DSY3220-1 | DSY3168 | TAC1-4/tac1-3Δ∷hisG, tac1∷TAC1-3 | This study |
| DSY3221-3 | DSY3168 | TAC1-4/tac1-3Δ∷hisG, tac1∷TAC1-4 | This study |
| DSY3053-2 | DSY3040 | TAC1-3/tac1-4Δ∷hisG-URA3-hisG | This study |
| DSY3168-2 | DSY3053-2 | TAC1-3/tac1-4Δ∷hisG | This study |
| DSY3222-2 | DSY3168-2 | TAC1-3/tac1-4Δ∷hisG, tac1∷TAC1-5 | This study |
| DSY3223-1 | DSY3168-2 | TAC1-3/tac1-4Δ∷hisG, tac1∷TAC1-3 | This study |
| DSY3224-1 | DSY3168-2 | TAC1-3/tac1-4Δ∷hisG, tac1∷TAC1-4 | This study |
| DSY296 | DSY294 | Azole-resistant clinical strain (MTLα/MTLα) | Coste et al. (2004) |
| DSY3041 | DSY296 | ura3Δ∷FRT/ura3Δ∷FRT | This study |
| DSY3059 | DSY3041 | TAC1-5/tac1-5Δ∷hisG-URA3-hisG | This study |
| DSY3076 | DSY3059 | TAC1-5/tac1-5Δ∷hisG | This study |
| DSY3210-1 | DSY3076 | TAC1-5/tac1-5Δ∷hisG, tac1∷TAC1-5 | This study |
| DSY3211-4 | DSY3076 | TAC1-5/tac1-5Δ∷hisG, tac1∷TAC1-3 | This study |
| DSY3215-1 | DSY3076 | TAC1-5/tac1-5Δ∷hisG, tac1∷TAC1-4 | This study |
| DSY3083 | DSY3076 | tac1-5Δ∷hisG/tac1-5Δ∷hisG-URA3-hisG | This study |
| DSY3090-8 | DSY3083 | tac1-5Δ∷hisG/tac1-5Δ∷hisG | This study |
| DSY3284-1 | DSY3090-8 | tac1-5Δ∷hisG/tac1-5Δ∷hisG, LEU2∷TAC1-5 | This study |
| DSY3285-1 | DSY3090-8 | tac1-5Δ∷hisG/tac1-5Δ∷hisG, LEU2∷TAC1-3 | This study |
| DSY3286-2 | DSY3090-8 | tac1-5Δ∷hisG/tac1-5Δ∷hisG, LEU2∷TAC1-4 | This study |
| FH1 | Azole-susceptible clinical strain (MTLa/MTLα) | Marr et al. (1997) | |
| FH3 | FH1 | Azole-resistant clinical strain (MTLα/MTLα) | Marr et al. (1997) |
| DSY3132-14 | FH1 | TAC1-7/tac1-6Δ∷FRT | This study |
| DSY3132-11 | FH1 | TAC1-6/tac1-7Δ∷FRT | This study |
| DSY3133-15 | FH3 | TAC1-7/tac1-7Δ∷FRT | This study |
| DSY3157-2 | FH1 | TAC1-6/TAC1-7/TAC1-7 | This study |
| DSY3301-4 | DSY3157-2 | TAC1-7/TAC1-7/TAC1-7 | This study |